1. Introduction {#s0005}
===============

Impairments of the ability to engage successfully in social interactions are well documented in schizophrenia (SCZ) and major depressive disorder (MDD) (e.g., [@bb0025], [@bb0005], [@bb0030], [@bb0020], [@bb0010], [@bb0035], [@bb0015]). In SCZ, these impairments of social interaction have been related to disturbances of self-related and other-related reasoning, i.e., social cognition (e.g., [@bb0040]). In particular, SCZ patients are thought to attribute more meaning to their social surroundings than usual, reflected in so-called positive symptoms such as delusions and paranoia ([@bb0045]). Alternatively, alterations of social cognition in SCZ have been described as a "loss of natural evidence" for being in a world intersubjectively shared with others, thereby leading to alienation and social withdrawal, which may culminate in a psychotic crisis, in which lost intersubjective meaning is replaced by a 'private' world of delusions ([@bb0050], [@bb0060], [@bb0055]). The latter changes have been related to the so-called negative symptom dimension of schizophrenia, which is also known to be highly relevant for prognosis and socio-economic outcome ([@bb0070], [@bb0065]).

In depressed patients, impairments of social interaction have similarly been related to attributional biases, which become manifest in abnormally increased, self-defeating, introspective thoughts and self-referential concerns ([@bb0075]). As in SCZ, disturbances of self-perception and self-referential thought can adversely affect interpersonal relations in MDD and make successful participation in social interaction difficult ([@bb0080], [@bb0085]). Furthermore, it has been recognized that negative interpersonal experiences throughout the life span constitute an important risk factor for the development of depression and have, thus, become a key target of psychotherapeutic interventions ([@bb0090]). Since social interactions are normally experienced as intrinsically rewarding ([@bb0095]), unsuccessful or reduced social interactions can further contribute to depressive symptomatology, but are also known to negatively affect the course of SCZ ([@bb0115], [@bb0110], [@bb0105], [@bb0100]).

Taken together, impairments of social interaction are well documented in both MDD and SCZ and can therefore be considered as a transdiagnostic symptom. The neurobiology that may underlie these transdiagnostic impairments, i.e., symptoms which fall onto a dimension that cuts across different nosological categories, in otherwise highly dissimilar disorders, however, remains poorly understood. In particular, when considering widespread dysconnectivity in both MDD and SCZ ([@bb0125], [@bb0120]), it is not clear whether transdiagnostically observed social impairments are subserved by distinct or common patterns of dysconnectivity. This question of similarities and differences in the neurobiological substrates of transdiagnostic social impairments is of particular relevance in light of current efforts of redefining psychiatric nosology in terms of neurobehavioral systems by taking a dimensional approach to the study of the genetic, neural, and behavioral features of mental disorders ([@bb0135], [@bb0140], [@bb0130]).

Previous neuroimaging evidence indicates that aberrations of introspective processes relevant for social interactions are related to changes of functional connectivity (FC) in key nodes of the very robust "default mode network" (DMN) in particular related to social processing ([@bb0145], [@bb0150], [@bb0155], [@bb0160], [@bb0165], [@bb0085], [@bb0170]). The DMN is classically defined as brain regions that show relative neural deactivation when focusing on the external environment and relative activation for internally focused tasks including autobiographic memory retrieval and conceiving the perspectives of others ([@bb0175]). Recently, a large-scale neuroimaging meta-analysis characterized the overlap of the DMN, emotional processing and social-cognitive networks ([@bb0180]). The spatial convergence was identified in two cortical midline regions, namely the dorsomedial prefrontal cortex (DMPFC) and precuneus including the posterior cingulate cortex (PRC/PCC) representing the anterior and the posterior hubs of the DMN, respectively ([Fig. 1](#f0005){ref-type="fig"}). Functionally, the DMPFC is involved in the generation of stimulus-independent thoughts about another person\'s mental states ([@bb0185]), while the PRC is frequently associated with internally directed attention ([@bb0190]). In order to assess dysconnectivity patterns that might be relevant for transdiagnostic social impairments, we used seed-based FC analyses of these two hubs of the DMN in groups of SCZ and MDD patients relative to cohorts of matched controls.

As the current study is based on the idea that transdiagnostic impairments of social interaction in SCZ and MDD may rely on common circuit dysfunction, we hypothesized to find similarities in functional dysconnectivity patterns, which may represent a common neurophysiological basis of the social deficits observed in both disorders.

2. Material & methods {#s0025}
=====================

2.1. Meta-analytically informed seed definition {#s0030}
-----------------------------------------------

For the current study, the seed regions of interest for the whole-brain FC analysis were derived from a quantitative meta-analysis on the statistical convergence of task-related neural deactivations in 533 experiments and increased activation in social-cognitive as well as in emotional tasks in 74 and 1474 experiments, respectively ([@bb0180]).

2.2. Sample description {#s0035}
-----------------------

In order to obtain a sufficient number of participants for robust statistics, samples of SCZ and MDD patients recruited in the hospital setting were pooled over different measurement sites ([Table 1](#t0005){ref-type="table"}) with each subsample being matched to a site-specific group of healthy controls (HC). As pooling over different MR scanners may introduce a systematic confound when comparing BOLD contrasts between scanners, every patient subsample was complemented with a group of closely matched HC of the same site. Thereby, group comparisons were based on a matched contribution of participants from every MR scanner minimizing the influence of MR scanner and EPI sequence parameters on group differences.

Patient and control groups for every site in both diseases were independently matched for age, sex and within scanner movements using the following procedure. For each subsample, 1,000,000 random samples of patient--control combinations were drawn and t-tests were computed for three movement parameters (see below) and age and chi-square tests for sex using MATLAB. Then, the biggest subsample of patients and controls with a p-value \> 0.2 in all tests was chosen to rule out any trend towards group difference regarding the applied parameters. Finally, the same matching criteria were used for the whole cohort in SCZ and MDD. Thereby, we assume that group differences in resting-state connectivity would neither be driven by systematically different head motion in the scanning process nor by differences in age or sex distribution. The SCZ sample included 75 patients and 82 controls from 4 scanning sites ([Table 2](#t0010){ref-type="table"}) and the MDD group consisted of 102 patients and 106 controls from 3 sites ([Table 3](#t0015){ref-type="table"}). Diagnosis was confirmed by clinical examination of the attending psychiatrist in accordance with the International Classification of Diseases (ICD-10). The two patient groups did not differ in terms of disease duration (mean duration: SCZ 9.03 ± 8.22; MDD 10.63 ± 10.20; Mann--Whitney U test: p = 0.72).

Due to recruitment taking place in a hospital setting and in light of around a decade long disease history, patients were medicated following established medication regimes. 80% of the SCZ patients were treated with second generation antipsychotics (SGA) and only a minority of 6.7% was receiving first generation antipsychotics (FGA) or a combination of the two (8%, [Table 4](#t0020){ref-type="table"}). 50% of the MDD cohort was prescribed selective serotonin reuptake inhibitors (SSRI), serotonin--norepinephrine reuptake inhibitors (SNRI) or norepinephrine--dopamine reuptake inhibitors (NDRI), while 16.7% were additionally taking Tricyclic antidepressants (TCA). TCA alone were taken by 15.7% of MDD patients and 5.9% were treated with SGA in combination with the two former agents or with reuptake inhibitors only (5.9%, [Table 5](#t0025){ref-type="table"}). It is important to note that systematically different medication for SCZ and MDD should have different within disease group effects on FC. This source of variance should rather make it more difficult to statistically detect similarities in connectivity aberrations over diseases, than representing a major confound to the transdiagnostic analysis. In addition, this more naturalistic setting should also allow better generalization of the FC results to the overall population of patients with depression and schizophrenia.

Healthy subjects for group comparisons did not have a history of neurological or psychiatric disorders and all subjects gave written informed consent to participate in the study as approved by the local ethics committees. The ethics committee at the HHU Düsseldorf also approved joint re-analysis of the data. All participants were instructed to lie still during the scanning session, keep their eyes closed (except for the participants from Göttingen) and to let their mind wander, but not to fall asleep. The latter was confirmed during a post-scan debriefing interview.

2.3. Resting state fMRI data: imaging & preprocessing {#s0040}
-----------------------------------------------------

For each subject resting state EPI images were acquired using standard blood-oxygen-level-dependent (BOLD) contrast \[gradient-echo EPI pulse sequence\]. Prior to further processing (using SPM8, [www.fil.ion.ucl.ac.uk/spm](http://www.fil.ion.ucl.ac.uk/spm){#ir0010}) the first four images were discarded allowing for magnetic field saturation. The EPI images were corrected for head movement by affine registration in a two-pass procedure realigning EPI volumes to its mean image. The mean EPI image for each subject was spatially normalized to the MNI single subject template using the "unified segmentation" approach ([@bb0195]). The ensuing deformation field was applied to the individual EPI volumes and smoothed with a 5-mm FWHM Gaussian kernel.

In recent years, it has repeatedly been shown that head motion is a crucial confounding factor in resting-state analysis leading to spurious connectivity estimates as well as artificial group differences (for review see [@bb0200]). In order to minimize the influence of motion artifacts on group comparisons, we conducted a matching of within scanner movements between patient and control subgroups. The following three head motion parameters were derived from the individual realignment parameters: i) framewise displacement (FD) represents the volume by volume movements ([@bb0205]), ii) root mean squared (RMS) movements indicating variance over voxels ([@bb0210]) and iii) DVARS as a combination of the former with D referring to temporal derivative of time courses and VARS referring to RMS variance over voxels ([@bb0215]). In these three parameters, neither patient and control subsamples nor the overall disease cohorts showed group differences (t-tests with p \> 0.2) indicating reasonably similar head motion in the scanning process of patients and healthy controls ([Tables 6](#t0030){ref-type="table"}+[7](#t0035){ref-type="table"}). In order to reduce spurious correlations between BOLD time courses through confounds such as physiological noise and motion, variance that could be explained by the following nuisance variables was removed from each voxel\'s time series: i) the six motion parameters derived from the image realignment and ii) their first derivative. According to published evaluations, motion regressors entered the model as first and second-order terms resulting in 24 movement regressors ([@bb0210]). In light of evidence suggesting that group comparisons may be distorted by correcting for the global mean signal ([@bb0225], [@bb0220]), no global signal regression was performed in the current study. Finally, data was band pass filtered preserving BOLD frequencies between 0.01 and 0.08 Hz ([@bb0230]).

2.4. Resting state fMRI data: individual & group level analyses {#s0045}
---------------------------------------------------------------

To quantify resting state FC of the meta-analytically defined DMPFC and PRC/PCC volumes of interest (VOI) for each subject, their time-series were extracted as the first eigenvariate of the gray matter voxels within the VOI. Linear Pearson correlations were computed for both VOIs with all other voxels\' time-series in every subject and correlation coefficients were Fischer\'s Z transformed for group comparison. A group-level ANOVA was calculated to directly compare group effects for SCZ and MDD patients in one model including regressors for both seed regions in each of the 4 groups resulting in 8 regressors (*SCZ*\[*DLPFC* + *PRC*/*PCC*\] + *HCscz*\[*2VOIs*\] + *MDD*\[*2VOIs*\] + *HCmdd*\[*2VOIs*\]).

Disorder-related changes in connectivity of both seeds were tested within each patient group relative to the respective control group, always in conjunction with the main effect of the respective seed\'s positive correlation in each control group (e.g., PRC/PCC\[HC~SCZ~ \> SCZ\] ∩ PRC/PCC\[HC~SCZ~\] ∩ PRC/PCC\[HC~MDD~\]). Within each group, conjunctions over both seeds\' FC changes were performed to analyze brain-wide FC aberrations. The same was done in both patient groups to assess transdiagnostic FC changes across SCZ and MDD.

Finally, disorder-specific differences in connectivity changes were explored by testing for an interaction effect between FC aberration and patient group, i.e., whether a given FC decrease in one patient group is bigger than the one observed in the other group (e.g., PRC/PCC\[HC~SCZ~ \> SCZ \> HC~MDD~ \> MDD\]), again in conjunction with the group-specific pattern of FC change. All results were corrected for multiple testing at the cluster level with a cluster-forming threshold of p \< 0.001 and thresholded at p \< 0.05 (cFWE).

3. Results {#s0010}
==========

3.1. Within-diagnosis connectivity differences {#s0050}
----------------------------------------------

SCZ patients relative to healthy controls HC showed widespread connectivity reduction of the PRC/PCC to many brain areas including inferior (IPL) and superior parietal lobule (SPL), medial and lateral premotor cortex (PMC), midcingulate cortex (MCC), the rolandic operculum (OP), superior temporal sulcus (STS) and occipital cortex, fusiform gyrus, primary sensorimotor cortex, cerebellum and the insula ([Fig. 2](#f0010){ref-type="fig"}A; MNI-coordinates in [Table 8](#t0040){ref-type="table"}). For the DMPFC, connectivity reduction in SCZ was found in a similar but less extensive network comprising SPL, IPL, STS, OP, left lateral and medial PMC, MCC, perigenual anterior cingulate cortex (pACC,) insula and left postcentral gyrus. The conjunction between FC reduction of the anterior and posterior hubs of the DMN revealed aberrant connectivity of MCC, supplementary motor area (SMA), bilateral SPL, OP and STS, posterior insula and secondary somatosensory cortex (SII). In MDD the PRC/PCC showed reduced FC with bilateral SPL ([Fig. 2](#f0010){ref-type="fig"}B). Reduced connectivity in MDD was also observed for the anterior node of the DMN with the DMPFC being less connected to left area 44. FC increases were not observed in any of the patient as compared to the respective control groups.

3.2. Transdiagnostic alterations in functional connectivity profiles {#s0055}
--------------------------------------------------------------------

The analysis of common connectivity alterations in both patient groups revealed a transdiagnostic reduction of FC between the PRC/PCC and bilateral SPL relative to their respective healthy control groups ([Fig. 3](#f0015){ref-type="fig"}; [Table 9](#t0045){ref-type="table"}).

3.3. Diagnosis-specific alterations in functional connectivity profiles {#s0060}
-----------------------------------------------------------------------

Differential changes in FC were found for SCZ patients, who showed a more pronounced connectivity reduction of the PRC/PCC with bilateral parietal OP than MDD patients ([Fig. 4](#f0020){ref-type="fig"}). Further investigation of the interaction effect between PRC/PCC-based FC reductions in SCZ as compared to MDD revealed an additional difference with less FC between PRC/PCC and the ventral striatum in SCZ as compared to MDD patients. The analysis of disorder-specific DMPFC connectivity differences showed a significant reduction of FC in SCZ to a smaller proportion of bilateral parietal OP.

4. Discussion {#s0015}
=============

In this study, we assessed transdiagnostic aberrations of resting state FC in SCZ and MDD patients using seed-based resting state analyses of the DMN ([@bb0180]). This investigation was based on the clinical insight that in spite of obvious phenomenological differences between disorders, both SCZ and MDD are also characterized by transdiagnostic symptoms (e.g., impairments of social interaction abilities), which may point towards common circuit dysconnectivity.

The results of our study, indeed, demonstrate shared, region-specific FC reductions of the DMN across both SCZ and MDD. This transdiagnostically observed dysconnectivity pattern included the precuneus and bilateral superior parietal cortex. Furthermore, we found evidence for differential connectivity alterations of the DMN in SCZ relative to MDD with more pronounced reductions of connectivity to both anterior and posterior nodes of the DMN in SCZ.

4.1. Within-diagnosis functional connectivity differences: Schizophrenia {#s0065}
------------------------------------------------------------------------

In line with previous research, our results demonstrate significant alterations of FC of the DMN in SCZ ([@bb0145], [@bb0240], [@bb0245], [@bb0250], [@bb0235]). In particular, the PRC/PCC has been implicated as a 'hot spot' for structural as well as FC aberrations in SCZ, which are not only observed across the entire clinical spectrum ([@bb0255]), but also appear to be related to relevant genetic variants ([@bb0245]). From a cognitive psychology perspective, it has been argued that FC of the PRC/PCC and other parietal areas may be particularly relevant for self-oriented processing and for providing a stable egocentric representation of space ([@bb0265], [@bb0260]). Furthermore, it has been argued that this network relevant for self-awareness might be particularly affected in SCZ ([@bb0270], [@bb0250]).

Dysconnectivity of the anterior hub of the DMN, i.e., the DMPFC, has also previously been associated with a familial risk for SCZ and its intrinsic connectivity is known to carry measurable consequences for social functioning ([@bb0275]). Consistent with these previous findings, our results demonstrate a significant reduction of FC for DMPFC with pACC, MCC, bilateral insula and STS, all of which are regions that are involved in cognitive control and self-monitoring processes and could, therefore, contribute to social abilities ([@bb0280], [@bb0285]). In particular, it has been demonstrated that DMPFC serves an important modulatory role by influencing activity in other brain regions when task requirements make it necessary ([@bb0290]). Therefore, alterations of DMPFC-based intrinsic connectivity as observed in SCZ patients may adversely affect cognitive processing by disallowing for such modulations to take place ([@bb0295]).

4.2. Within-diagnosis functional connectivity differences: Depression {#s0070}
---------------------------------------------------------------------

Within the MDD group connectivity reductions of the posterior node of the DMN, i.e., PRC/PCC, was found to bilateral SPL, which constitutes a striking parallel to the findings in the SCZ group. While alterations of SPL activity at rest are less often described in the literature to be associated with MDD ([@bb0300]), the structural connection between bilateral SPL was found to discriminate depressed patients from controls in a classification analysis using diffusion tractography ([@bb0305]). With regard to symptom severity, an increase in PRC/PCC activation was found for depressed patients responding to treatment with fluoxetine ([@bb0310]) as well as for deep brain stimulation ([@bb0315]).

Reduced connectivity in MDD was also observed for the anterior node of the DMN, as indicated by a significant reduction of DMPFC connectivity with left inferior frontal gyrus. These two regions and their co-activation patterns are known to be relevant for planning, carrying out and responding to actions, in particular when they occur in a social context ([@bb0320]), which can be disturbed in MDD. Consistently, both regions have also previously been found to show aberrant activation patterns in patients relative to controls for tasks that are typically associated with depressive symptomatology ([@bb0325]).

4.3. Transdiagnostic similarities in functional connectivity alterations {#s0075}
------------------------------------------------------------------------

Based on the assumption that phenotypic commonalities could rely on common brain circuit dysfunction ([@bb0135]), we conducted an analysis of transdiagnostic similarities in connectivity alterations across SCZ and MDD patients relative to the respective control groups. This analysis demonstrated a significant reduction of FC between PRC/PCC and bilateral SPL across both patient groups. Interestingly, the interaction of medial and lateral parietal networks has been shown to be important for regulating the balance between internally and externally directed attention ([@bb0330]). More specifically, the brain regions implicated (PRC/PCC and SPL) have both been associated with top-down control of attention and indirectly with sensorimotor integration and are thus thought to provide a coherent self-representation across space and time ([@bb0335]). While SPL activity change has been linked to spatial shifts of attention ([@bb0340]), precuneus has been linked to non-spatial shifts of attention ([@bb0345]). Further evidence has demonstrated strong reciprocal relations between activity in these two regions, which have been discussed as contributing to a finely tuned interplay between stimulus-oriented and stimulus-independent cognition (e.g., [@bb0350]).

Fittingly, both SCZ and MDD are associated with a dysbalance between internally and externally directed attention and mental state attribution: While patients with MDD are known to attribute internally when making sense of external occurrences and tend to do so in a self-defeating manner, patients with SCZ often use an externalizing bias in the attribution of causation of social events ([@bb0355]). Social difficulties in both disorders could, therefore, be related to such negative self-referential thoughts, distorted attributional biases and the subsequent development of anxiety. Also, patients from both diagnostic groups often withdraw from social contexts, which may lead to a further consolidation of disorder-specific symptomatology. It is tempting to speculate that these social impairments could be related to common dysconnectivity patterns of posterior nodes of DMN that are present in both patient groups, but unfortunately no measures of social behavior were available in our study to directly investigate this putative association.

4.4. Disorder-specific differences in functional connectivity alterations {#s0080}
-------------------------------------------------------------------------

Finally, we explored disorder-specific differences in FC by testing whether observed connectivity alterations are more pronounced in one patient group than in the other. This analysis revealed a specifically reduced connectivity pattern in SCZ patients for PRC/PCC and DMPFC with the parietal operculum. In general, disruption of the parietal operculum has already been demonstrated in SCZ ([@bb0365], [@bb0360]) and is well in line with cognitive functions associated with this structure, such as interoceptive awareness, multisensory integration and body perception ([@bb0380], [@bb0375], [@bb0370]). In light of these findings, dysconnectivity of the parietal operculum may represent a disorder-specific aspect of SCZ that could be linked to alterations of a basic sense of self. Furthermore, it is conceivable that activity alterations of this region feed into or trigger higher-order self-processing disturbances and subsequent misattributions of mental states, which could be related to activity changes of medial parietal or dorsomedial prefrontal cortex ([@bb0390], [@bb0395], [@bb0385]). Taken together, the reduced coupling of OP with the DMN in SCZ may represent an important and disorder-specific pathophysiological mechanism for self-disturbances in SCZ.

Furthermore, disorder-specific connectivity differences in SCZ as compared to MDD were also found for the ventral striatum, which has been strongly linked to reward processing ([@bb0400]). In schizophrenia, ventral striatal activity has furthermore been related to the concept of "aberrant salience", according to which a deregulated state of activity can lead to "an aberrant assignment of salience to elements of one\'s experience" and whereby hallucinations "reflect a direct experience of the aberrant salience of internal representations" ([@bb0405]). Accordingly, clinical studies of visual and auditory hallucinations have demonstrated alterations of ventral striatal connectivity ([@bb0235]). Our findings corroborate these findings by documenting that ventral striatal dysconnectivity is significantly associated with SCZ rather than MDD.

4.5. Limitations {#s0085}
----------------

The design of the current study, which draws upon the possibility of data pooling over several measurement sites as well as two psychiatric disorders, includes the following important drawbacks. From a methodological point of view, combining data from multiple sites entails the risk of finding spurious effects due to systematic differences between sample recruitment and the measurement of behavioral and imaging data or solely due to the comparison of different scanners. To minimize the influence of measurement site on group comparisons, one should control for systematic differences in confounding factors like age, gender or within scanner movement between sites. Another approach would be to explicitly modeling measurement site as a variable of no interest, which becomes difficult when dealing with more than two sites, as the actual amount of difference will certainly be unequal between sites. Therefore, and to retain as much variance in the data as possible we applied the former strategy and independently matched groups of patients and controls within every site and disease for age, sex and within scanner movements. As there were no significant differences of these factors within each subsample as well as in the overall cohorts for both diseases, group comparisons should not significantly be driven by site differences. Moreover, due to the data pooling procedure implemented in our study with the aim of maximizing sample size, we were not able to collect representative data on the state of social impairments in both patient groups. This fact clearly limits the generalizability of the presented FC decrease as to their specificity for social impairments. Even though, transdiagnostic dysconnectivity between PRC/PCC and SPL could be shown for both MDD and SCZ, its co-variation with severity of social impairments in general, as well as with particular disabilities in social behavior, remains to be shown. As resting-state FC is a very indirect measure of these social-cognitive processes, connectivity modeling based on task-based studies would be needed to directly relate the transdiagnostic findings observed in our study to individual clinical symptomatology, attributional styles and real-life social functioning. Furthermore, future research could use connectivity measures to evaluate network dysfunction during the course of illness with the aim of predicting the effects of various treatment options.

5. Conclusions {#s0020}
==============

Taken together, our study provides first-time evidence for commonalities in transdiagnostic functional connectivity alterations of the DMN in SCZ and MDD. These findings at the neural level parallel descriptions of phenotypic commonalities across both disorders, which exist next to disorder-specific disturbances and have emphasized impairments of social interaction (for a review see [@bb0035]). In light of these findings, it is tempting to speculate that phenotypic overlap could be related to common brain circuit dysfunction. Unfortunately, no measures of social behavior were available in the patient samples here described to further investigate this possible relationship. In terms of the neurofunctional alterations present in both disorders groups, previous research can be taken to suggest that medial and superior parietal cortex dysconnectivity may lead to a disturbance of the finely tuned and flexible balance between internally and externally directed attention. In addition to this, dysconnectivity of the DMN could also be related to well known differences in attributional style that patients use to make sense of the environment.

Furthermore, our analysis demonstrates that disorder-specific differences also exist as indexed by more strongly reduced coupling of the parietal operculum with the DMN in SCZ as compared to MDD. In light of previous research, which has convincingly demonstrated that the operculum plays an important role in somatosensory integration and body perception and that SCZ is associated with a disruption of activity in this brain region, this finding of opercular dysconnectivity with the DMN may represent an important and disorder-specific pathophysiological mechanism for self-disturbances in SCZ. In particular, one could speculate that activity alterations of the operculum may trigger additional self-processing disturbances and could thereby lead to subsequent misattributions of mental states.
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![Meta-analytically defined default mode network. Taken from [@bb0180], precuneus including posterior cingulate cortex: PRC/PCC MNI: x − 4, y − 54, z 24, dorso-medial prefrontal cortex: DMPFC MNI: x − 2, y 52, z 14.](gr1){#f0005}

![Results of *within-diagnosis* analyses: A) FC reduction of PRC/PCC and DMPFC in patients with schizophrenia relative to healthy controls and their overlap. B) FC reduction of PRC and DMPFC in patients with depression relative to healthy controls.](gr2){#f0010}

![Transdiagnostic *similarities* in functional connectivity alterations: Reduction of FC between PRC/PCC and bilateral superior parietal cortex across *both* diagnostic groups relative to healthy controls.](gr3){#f0015}

![Transdiagnostic *differences* in functional connectivity alterations: A) More pronounced reduction of FC from PRC/PCC and DMPFC with bilateral operculum and B) the ventral striatum in SCZ \< CON relative to MDD \< CON.](gr4){#f0020}

###### 

Scanning parameters across sites.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Schizophrenia                                                                                                                                   
  ---------------------------------------- --------------------------------------- ---------------------------------- --------------------------- ----------------------------------
  *Aachen*\                                *Aachen \#2*\                           *Göttingen*\                       *Utrecht*\                  *Lille*\
  Siemens TrioTim\                         Siemens TrioTim\                        Siemens TrioTim\                   Philips Achieva 3 T\        IRM Philips 3 T\
  TR: 2200 ms\                             TR: 2000 ms\                            TR: 2000 ms\                       TR: 609 ms\                 TR: 1000 ms\
  TE: 30 ms\                               TE: 28 ms\                              TE: 30 ms\                         TE: 32.4 ms\                TE: 9.6 ms\
  Number of slices: 36\                    Number of slices: 34\                   Number of slices: 33\              Number of slices: 40\       Number of slices: 45\
  Slice-thickness: 3.2 mm\                 Slice-thickness: 3.3 mm\                Slice-thickness: 3 mm\             Flip-angle: 10∞\            Slice-thickness: 3.4\
  Gap: 3.84 mm\                            Gap: 3.6 mm\                            Gap: 0.6 mm\                       Voxel-size: 4 × 4 × 4 mm\   Flip-angle: 9\
  Flip-angle: 77∞\                         Flip-angle: 77∞\                        Flip-angle: 70∞\                   FOV: 224 × 256 × 160\       Voxel-size: 3.219 × 3.219 × 3.4\
  Orientation: axial\                      Orientation: axial\                     Orientation: axial\                Matrix: 64 × 64 × 40\       Orientation: SAG
  In-plane resolution: 3.1 × 30.1 mm^2^    In-plane resolution: 3.6 × 3.6 mm^2^    In-plane resolution: 3 × 3 mm^2^   Orientation: coronal        

                                                                                                                                                  

  Major depressive disorder                                                                                                                       

                                                                                                                                                  

  *Aachen*\                                *Munich*\                               *Göttingen*\                                                   
  Siemens TrioTim\                         Philips Achieva 3 T\                    Siemens TrioTim\                                               
  TR: 2200 ms\                             TR: 2000 ms\                            TR: 2000 ms\                                                   
  TE: 30 ms\                               TE: 35 ms\                              TE: 30 ms\                                                     
  Number of slices: 36\                    Number of slices: 32\                   Number of slices: 33\                                          
  Slice-thickness: 30.2 mm\                Slice-thickness: 4 mm\                  Slice-thickness: 3 mm\                                         
  Gap: 3.84 mm\                            Gap: 0\                                 Gap: 0.6 mm\                                                   
  Flip-angle: 77∞\                         Flip-angle: 82∞\                        Flip-angle: 70∞\                                               
  Orientation: axial\                      Orientation: AC/PC\                     Orientation: axial\                                            
  In-plane resolution: 30.1 × 30.1 mm^2^   In-plane resolution: 2.3 × 20.3 mm^2^   In-plane resolution: 3 × 3 mm^2^                               
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Group characteristics for schizophrenia (SCZ); SD: standard deviation.

                  SCZ patients    Healthy controls   Statistical comparison
  --------------- --------------- ------------------ ------------------------
  Participants    n =             n =                
   Entire group   75              82                 
   Aachen         13              13                 
   Aachen \#2     13              15                 
   Utrecht        10              10                 
   Göttingen      30              35                 
   Lille          9               9                  
  Sex             Male/female     Male/female        Chi^2^ test
   Entire group   54/23           59/23              0.9946
   Aachen         8/5             8/5                1.0000
   Aachen \#2     11/2            12/3               0.7505
   Utrecht        5/5             5/5                1.0000
   Göttingen      24/6            28/7               1.0000
   Lille          11/3            11/3               1.0000
  Age             Mean ± SD       Mean ± SD          ttest/ranksum
   Entire group   33.46 ± 9.61    33.79 ± 10.36      0.8372/0.9579
   Aachen         38.54 ± 8.52    38.62 ± 10.29      0.9836/1.0000
   Aachen \#2     33.38 ± 10.40   33.40 ± 11.36      0.9971/1.0000
   Utrecht        32.68 ± 9.29    35.90 ± 12.99      0.5314/0.6769
   Göttingen      31.27 ± 9.59    32.46 ± 9.44       0.6166/0.3936
   Lille          34.44 ± 9.58    30.33 ± 8.26       0.3441/0.1371

###### 

Group characteristics for major depression disorder (MDD). SD: standard deviation.

                  MDD patients    Healthy controls   Statistical comparison
  --------------- --------------- ------------------ ------------------------
  Participants    n =             n =                
   Entire group   102             106                
   Göttingen      49              51                 
   Aachen         30              30                 
   Munich         23              25                 
  Sex             Male/female     Male/female        Chi^2^
   Entire group   49/53           51/55              0.9915
   Göttingen      27/22           29/22              0.8593
   Aachen         11/19           11/19              1.0000
   Munich         11/12           11/14              0.7904
  Age             Mean ± SD       Mean ± SD          ttest/ranksum
   Entire group   37.75 ± 13.29   36.99 ± 12.92      0.6784/0.6356
   Göttingen      34.00 ± 10.55   34.04 ± 10.92      0.9855/0.8306
   Aachen         36.10 ± 12.21   36.10 ± 12.58      1.0000/0.8648
   Munich         47.87 ± 15.14   44.08 ± 14.78      0.3849/0.4029

###### 

Overview of medication in the schizophrenia cohort. SGA: second generation antipsychotics; FGA: first generation antipsychotics.

  Schizophrenia    n =   SGA   FGA    SGA & FGA   Missing data
  ---------------- ----- ----- ------ ----------- --------------
  Aachen (n)       13    12    --     --          1
  Aachen \#2 (n)   13    12    1      --          0
  Göttingen (n)    30    25    --     4           1
  Utrecht (n)      10    3     3      2           2
  Lille (n)        9     8     1      --          0
  Overall (%)      75    80%   6.7%   8%          5.3%

###### 

Overview of medication in the major depression cohort (MDD). SSRI: selective serotonin reuptake inhibitors; SNRI: serotonin--norepinephrine reuptake inhibitors; NDRI: norepinephrine--dopamine reuptake inhibitor; TCA: tricyclic antidepressants; SGA: second generation antipsychotics.

  MDD             n =   SSRI/SNRI/NDRI   SSRI/SNRI/NDRI & TCA   TCA     SSRI/SNRI/NDRI & SGA   SSRI/SNRI/NDRI & TCA & SGA   Other/none
  --------------- ----- ---------------- ---------------------- ------- ---------------------- ---------------------------- ------------
  Aachen (n)      30    19               4                      1       2                      3                            1
  Munich (n)      23    9                8                      4       2                      --                           --
  Göttingen (n)   49    24               5                      11      2                      3                            2/2
  Overall (%)     102   51%              16.7%                  15.7%   5.9%                   5.9%                         4.9%

###### 

Comparison of within-scan motion parameters for schizophrenia (SCZ); DVARS: temporal derivative of time courses cf. Power 2012, FD: frame wise displacement cf. [@bb0205], RMS: variance over voxels cf. [@bb0210]. SD: standard deviation.

                 SCZ patients   Healthy controls   Statistical comparison p-values
  -------------- -------------- ------------------ ---------------------------------
  DVARS                                            
  Entire group   1.40 ± 0.30    1.35 ± 0.32        0.2695/0.1893
  Aachen         1.58 ± 0.26    1.54 ± 0.24        0.6894/0.7196
  Aachen \#2     1.20 ± 0.22    1.11 ± 0.16        0.2721/0.4336
  Utrecht        1.80 ± 0.22    1.85 ± 0.18        0.5690/0.4274
  Göttingen      1.22 ± 0.18    1.17 ± 0.19        0.2776/0.1388
  Lille          1.62 ± 0.12    1.59 ± 0.23        0.7763/0.4894
                                                   
  FD                                               
  Entire group   0.28 ± 0.13    0.26 ± 0.10        0.1754/0.4405
  Aachen         0.34 ± 0.17    0.30 ± 0.11        0.5297/0.9183
  Aachen \#2     0.30 ± 0.15    0.26 ± 0.09        0.3639/0.7125
  Utrecht        0.29 ± 0.11    0.25 ± 0.04        0.2769/0.8501
  Göttingen      0.22 ± 0.07    0.23 ± 0.09        0.6033/0.8487
  Lille          0.40 ± 0.12    0.33 ± 0.15        0.2953/0.1903
                                                   
  RMS                                              
  Entire group   0.21 ± 0.10    0.19 ± 0.07        0.1384/0.3902
  Aachen         0.25 ± 0.13    0.22 ± 0.08        0.5226/0.6816
  Aachen \#2     0.22 ± 0.11    0.19 ± 0.07        0.2936/0.4611
  Utrecht        0.20 ± 0.08    0.17 ± 0.03        0.3041/0.7913
  Göttingen      0.16 ± 0.05    0.16 ± 0.07        0.6251/0.8590
  Lille          0.29 ± 0.10    0.23 ± 0.10        0.2178/0.1615

###### 

Comparison of within-scanner motion parameters for major depression disorder (MDD); DVARS: temporal derivative of time courses cf. Power 2012, FD: frame wise displacement cf. [@bb0205], RMS: variance over voxels cf. [@bb0210]. SD: standard deviation.

                 MDD patients   Healthy controls   Statistical comparison p-values
  -------------- -------------- ------------------ ---------------------------------
  *DVARS*                                          
  Entire group   1.31 ± 0.30    1.29 ± 0.26        0.6299/0.8420
  Göttingen      1.22 ± 0.21    1.18 ± 0.17        0.2894/0.4819
  Aachen         1.52 ± 0.32    1.55 ± 0.26        0.6464/0.6414
  Munich         1.22 ± 0.30    1.20 ± 0.19        0.7448/0.8365
                                                   
  *FD*                                             
  Entire group   0.26 ± 0.14    0.25 ± 0.11        0.3909/0.6490
  Göttingen      0.26 ± 0.15    0.23 ± 0.11        0.2773/0.4606
  Aachen         0.28 ± 0.14    0.31 ± 0.11        0.5243/0.4376
  Munich         0.24 ± 0.10    0.21 ± 0.08        0.2905/0.3119
                                                   
  *RMS*                                            
  Entire group   0.19 ± 0.10    0.18 ± 0.08        0.3891/0.6195
  Göttingen      0.19 ± 0.11    0.17 ± 0.08        0.3067/0.4441
  Aachen         0.21 ± 0.10    0.22 ± 0.08        0.5895/0.4119
  Munich         0.17 ± 0.07    0.15 ± 0.06        0.3054/0.3119

###### 

Results of *within-diagnosis* analyses. Suprathreshold clusters at a height threshold of p = 0.05 cluster-level corr. and a cluster-forming threshold of p~uc~ \< 0.001. MNI coordinates of principally activated voxels for each cluster are given; assignment to anatomical locations carried by using the SPM Anatomy toolbox.

  Macroanatomical location                                 x      y       z      k       T
  -------------------------------------------------------- ------ ------- ------ ------- ------
  \[SCZ \< CON\]~PRC~[Fig. 2](#f0010){ref-type="fig"}A                                   
  Superior parietal lobule                                 12     − 38    48     17022   6.64
  Right fusiform gyrus                                     52     − 50    − 24   1185    5.32
  Left fusiform gyrus                                      − 50   − 48    − 12   500     5.00
  Left V3                                                  − 24   − 100   − 14   336     5.05
  Left rolandic operculum                                  − 58   0       6      219     4.79
  Left inferior parietal lobule                            − 38   − 74    20     200     4.53
  Left anterior insula                                     − 32   24      2      137     4.83
  Right cerebellum                                         32     − 44    − 52   136     5.07
  Left precuneus                                           − 20   − 48    20     103     5.39
  Right precuneus                                          26     − 56    16     102     4.56
                                                                                         
  \[SCZ \< CON\]~DMPFC~[Fig. 2](#f0010){ref-type="fig"}B                                 
  Right insula lobe                                        36     4       10     2473    5.42
  Left superior temporal gyrus                             − 58   − 22    12     1802    5.73
  Right anterior cingulate cortex                          2      18      28     1413    5.38
  Right precuneus                                          12     − 76    54     1105    4.72
  Posterior-medial frontal cortex                          0      − 14    66     351     4.32
  Left postcentral gyrus                                   − 50   − 8     46     141     4.14
  Left insula lobe                                         − 40   4       − 10   134     5.09
  Left middle temporal gyrus                               − 50   − 58    − 4    118     4.10
  Left precuneus                                           − 10   − 42    58     101     4.10
                                                                                         
  \[MDD \< CON\]~PRC~[Fig. 2](#f0010){ref-type="fig"}C                                   
  Right superior parietal cortex                           20     − 52    64     453     4.96
  Left superior parietal cortex                            − 16   − 62    62     315     4.83
                                                                                         
  \[MDD \< CON\]~DMPFC~[Fig. 2](#f0010){ref-type="fig"}D                                 
  Left precentral gyrus                                    − 58   12      32     312     4.64

###### 

Results of *transdiagnostic* analyses. Suprathreshold clusters at a height threshold of p = 0.05 cluster-level corr. and a cluster-forming threshold of p~uc~ \< 0.001. MNI coordinates of principally activated voxels for each cluster are given; assignment to anatomical locations carried by using the SPM Anatomy toolbox.

  Macroanatomical location                                                          x      y      z     k     T
  --------------------------------------------------------------------------------- ------ ------ ----- ----- ------
  \[PAT \< CON\]~PRC~                                                                                         
  Right superior parietal cortex                                                    20     − 52   64    389   4.91
  Left superior parietal cortex                                                     − 16   − 54   68    291   4.83
                                                                                                              
  \[SCZ \< CON\] relative to \[MDD \< CON\]~PRC/PCC~                                                          
  Right rolandic operculum                                                          58     − 18   18    346   4.52
  Left rolandic operculum                                                           − 52   − 12   14    121   3.95
                                                                                                              
  \[SCZ \< CON\] relative to \[MDD \< CON\]~PRC/PCC~ inclusively masked p \< 0.05                             
  Right rolandic operculum                                                          58     − 18   18    361   4.53
  Left rolandic operculum                                                           − 50   − 14   14    133   4.41
  Right caudate nucleus                                                             8      18     − 4   110   4.75
                                                                                                              
  \[SCZ \< CON\] relative to \[MDD \< CON\]~DMPFC~                                                            
  Right rolandic operculum                                                          62     − 20   22    112   3.92
  Left rolandic operculum                                                           − 52   − 12   14    110   4.67
                                                                                                              
  \[SCZ \< CON\] relative to \[MDD \< CON\]~DMN~                                                              
  Right rolandic operculum                                                          62     − 20   22    67    3.92
  Left rolandic operculum                                                           − 52   − 12   14    56    3.95

[^1]: These authors contributed equally.
